Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Moaven

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Medical Journal of Australia|November 6, 1998
Should we be screening blood donors for hepatitis G virus? The case for screeningL D Moaven
The Medical Journal of Australia|April 19, 1993
Hepatitis C virus infection in Victorian injecting drug users in 1971L D Moaven, N Crofts, S A Locarnini
The Medical Journal of Australia|March 1, 1993
Passive immunisation against hepatitis C infectionL D Moaven, S A Locarnini, P Schiff
The Medical Journal of Australia|January 15, 1996
New hepatitis viruses: are there enough letters in the alphabet?D S Bowden, L D Moaven, S A Locarnini
The Medical Journal of Australia|March 18, 2000
Sporotrichosis mimicking necrotising arachnidismL D Moaven, S A Altman, A R Newnham
The Pediatric Infectious Disease Journal|June 1, 1994
Parvovirus B19-associated red blood cell aplasia in combined immunodeficiency with normal immunoglobulinsM L Tang, A S Kemp, L D Moaven
The Medical Journal of Australia|August 19, 1996
The changing prevalence of hepatitis C virus types in injecting drug users between 1971 and 1994L D Moaven, N Crofts, R McCaw, et al.
The Medical Journal of Australia|July 15, 1996
Mother-to-baby transmission of hepatitis G virusL D Moaven, P S Tennakoon, D S Bowden, et al.
The Medical Journal of Australia|May 5, 1997
Prevalence of hepatitis G virus antibodies in Queensland blood donorsL D Moaven, I F Young, D S Bowden, et al.
Lancet (London, England)|November 29, 1986
Foscarnet in fulminant hepatitis BJ S Price, A J France, L D Moaven, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Medical Journal of Australia|November 6, 1998
Should we be screening blood donors for hepatitis G virus? The case for screeningL D Moaven
The Medical Journal of Australia|April 19, 1993
Hepatitis C virus infection in Victorian injecting drug users in 1971L D Moaven, N Crofts, S A Locarnini
The Medical Journal of Australia|March 1, 1993
Passive immunisation against hepatitis C infectionL D Moaven, S A Locarnini, P Schiff
The Medical Journal of Australia|January 15, 1996
New hepatitis viruses: are there enough letters in the alphabet?D S Bowden, L D Moaven, S A Locarnini
The Medical Journal of Australia|March 18, 2000
Sporotrichosis mimicking necrotising arachnidismL D Moaven, S A Altman, A R Newnham
The Pediatric Infectious Disease Journal|June 1, 1994
Parvovirus B19-associated red blood cell aplasia in combined immunodeficiency with normal immunoglobulinsM L Tang, A S Kemp, L D Moaven
The Medical Journal of Australia|August 19, 1996
The changing prevalence of hepatitis C virus types in injecting drug users between 1971 and 1994L D Moaven, N Crofts, R McCaw, et al.
The Medical Journal of Australia|July 15, 1996
Mother-to-baby transmission of hepatitis G virusL D Moaven, P S Tennakoon, D S Bowden, et al.
The Medical Journal of Australia|May 5, 1997
Prevalence of hepatitis G virus antibodies in Queensland blood donorsL D Moaven, I F Young, D S Bowden, et al.
Lancet (London, England)|November 29, 1986
Foscarnet in fulminant hepatitis BJ S Price, A J France, L D Moaven, et al.
Pageof 2